You are not logged in so some information on this page has been withheld. To see more, please log in.

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

found 2025 › Jul › 09 (Wed) @ 13:30 UTC

Canada ■■
Novo Nordisk ■■
Novo ■■
Nordisk ■■
Ozempic ■■
Wegovy ■■

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.